Role of Direct Antiviral Agents in Treatment of Chronic Hepatitis C Infection in Renal Transplant Recipients

Table 4

Adverse events reported while on DAA therapy.

Adverse events	Sofosbuvir/Ribavirin	Sofosbuvir/Daclatasvir	Sofosbuvir/Ledipasvir	Total
Anaemia	11	1	0	12
Diarrhoea	9	2	1	12
Headache	6	1	3	10
Nausea	4	4	2	10
Leucopenia	3	0	0	3
Thrombocytopenia	3	0	0	3
Influenza-like illness	2	0	0	2
Myalgia	1	1	0	2
Graft dysfunction	1	0	1	2